NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
09/10/2025
Back to search
Official data from USPTO
CLINICAL RESEARCHER
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
CLINICAL RESEARCHER
ST13
US500000086538663Class
16, 41
Filing
86538663
Registration
4783729
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
22
Latest update
09/11/2025
Trademark type
Word
Nice classes
16, 41
Filing date
02/18/2015
Registration date
07/28/2015
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
09/10/2025
Last transaction
09/11/2025
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Supplemental Register
First use anywhere
03/01/2014
First use in commerce
04/26/2014
Drawing code
4
Owner type
99
Owner location
Alexandria, VA
Examiner
PINO, BRIAN
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Association of Clinical Research Professionals, Inc.
Representatives
Andrew D. Price & Paula E. Hopkins Venable Llp
Technical classification
Nice Classes
Class 16Class 41
Vienna Codes
No Vienna codes available.
Goods and services
Class 16
Peer-reviewed journals in the field of clinical trends in relation to conducting human studies for the development of new drugs and medical devices
Class 41
Providing an on-line publicationa peer-reviewed journal in the field of clinical trends in relation to conducting human studies for the development of new drugs and medical devices
Publications
History of USPTO decisions and trademark events.
22 publications found
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
09/10/2025
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
09/10/2025
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
09/08/2025
E89R
TEAS SECTION 8 & 9 RECEIVED
05/07/2025
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
07/28/2024
NAS8
NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
01/04/2022
8.PR
REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED
01/04/2022
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
01/04/2022
ES8R
TEAS SECTION 8 RECEIVED
07/28/2021
R.SR
REGISTERED-SUPPLEMENTAL REGISTER
07/28/2015
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
06/19/2015
ALIE
ASSIGNED TO LIE
06/19/2015
CNTA
APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
06/02/2015
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/01/2015
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/01/2015
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
06/01/2015
CNRT
NON-FINAL ACTION MAILED
05/13/2015
CNRT
NON-FINAL ACTION WRITTEN
05/12/2015
DOCK
ASSIGNED TO EXAMINER
05/06/2015
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
03/05/2015
NWAP
NEW APPLICATION ENTERED
02/21/2015
Continuous trademark protection
Get notified about every new filing that threatens CLINICAL RESEARCHER or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.